| Date Filed | Type | Description |
| 02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 51,300 shares
@ $0
Granted 307,500 options to buy
@ $3.02, valued at
$928.7k
|
|
| 01/11/2023 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,855 shares
@ $3, valued at
$17.6k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,080 shares
@ $6.27, valued at
$31.9k
|
|
| 01/05/2022 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 42,300 shares
@ $0
Granted 253,500 options to buy
@ $6.9, valued at
$1.7M
|
|
| 01/21/2021 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 202,000 options to buy
@ $19.82, valued at
$4M
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/13/2020 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 790,274 shares
@ $0
Granted 50,000 shares
@ $0
Granted 111,250 options to buy
@ $31.5, valued at
$3.5M
|
|
| 01/13/2020 |
3
| Shefferman Jesse (CEO and President) has filed a Form 3 on ArTara Therapeutics, Inc. |